What makes artesunate a promising treatment?
Artesunate, an injectable form of the antimalarial drug artemisinin, has shown significant efficacy in treating severe malaria. Research suggests that artesunate may have a better therapeutic index compared to other artemisinin-based therapies, which means it may be more effective with fewer side effects [1].
How does artesunate compare to artemether and lumefantrine?
Studies have demonstrated that artesunate is more effective than artemether and lumefantrine in reducing parasite clearance half-life, a measure of how quickly the parasite count decreases in the blood [2]. This suggests that artesunate may be a superior option for treating severe malaria.
What about the differences between intravenous and intramuscular artesunate?
Clinical trials have shown that intravenous artesunate is more effective than intramuscular artesunate in treating severe falciparum malaria, particularly in patients with high parasite loads [3]. However, more research is needed to confirm the findings and determine the optimal route of administration.
Why are some hospitals turning to artesunate over other treatments?
The ease of preparation and administration of artesunate compared to other treatments, such as artesunate-based combination therapies, may make it an attractive option for hospitals. Additionally, the lower cost of artesunate compared to some other antimalarial treatments, such as Keytruda, may make it a more viable option for patients [4].
What are the current patent and exclusivity status of artesunate?
Artesunate's patents have expired in some regions, which may enable the development of generic or biosimilar versions of the drug [5]. However, it is essential to note that the patent and exclusivity status of artesunate can vary depending on the country and region.
Sources:
[1] [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445141/]
[2] [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391115/]
[3] [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445143/]
[4] [https://www.drugpatentwatch.com/drug/ar العربيةtesunate]
[5] [https://www.drugpatentwatch.com/drug/ar العربيةtesunate]